SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
D/A
Other
View HTML
D/A
Other
View HTML
S-1

Registration statement for face-amount certificate companies

Registration Statements
View HTML
D/A
Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
RW

Withdrawal of registration statement filed under the Securities Act

Other
View HTML
RW

Withdrawal of registration statement filed under the Securities Act

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML

Data provided by Kaleidoscope.